BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31159549)

  • 1. Growth of colorectal liver metastases is not accelerated by intraportal administration of stem cells after portal vein embolization.
    Brůha J; Treska V; Mírka H; Hosek P; Fichtl J; Skalický T; Bajcurová K; Ludvík J; Duras P; Lysák D; Liska V
    Rozhl Chir; 2019; 98(4):159-166. PubMed ID: 31159549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Portal vein embolisation with application of haematopoietic stem cells in patients with primarily or non-resectable colorectal liver metastases.
    Treska V; Liska V; Fichtl J; Lysak D; Mirka H; Bruha J; Duras P; Treskova I; Nahlik J; Simanek V; Topolcan O
    Anticancer Res; 2014 Dec; 34(12):7279-85. PubMed ID: 25503161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Portal Vein Embolization (PVE)
    Treska V; Fichtl J; Ludvik J; Bruha J; Liska V; Treskova I; Kucera R; Topolcan O; Lysak D; Skalicky T; Ferda J
    Anticancer Res; 2018 Sep; 38(9):5531-5537. PubMed ID: 30194213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methods to Increase Future Liver Remnant Volume in Patients with Primarily Unresectable Colorectal Liver Metastases: Current State and Future Perspectives.
    Treska V
    Anticancer Res; 2016 May; 36(5):2065-71. PubMed ID: 27127106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Portal Vein Embolization with Contralateral Application of Stem Cells Facilitates Increase of Future Liver Remnant Volume in Patients with Liver Metastases.
    Ludvík J; Duras P; Třeška V; Matoušková T; Brůha J; Fichtl J; Lysák D; Ferda J; Baxa J
    Cardiovasc Intervent Radiol; 2017 May; 40(5):690-696. PubMed ID: 28091729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive Value of Growth Factors and Interleukins for Future Liver Remnant Volume and Colorectal Liver Metastasis Volume Growth Following Portal Vein Embolization and Autologous Stem Cell Application.
    Fichtl J; Treska V; Lysak D; Mirka H; Duras P; Karlikova M; Skalicky T; Vodička J; Topolcan O
    Anticancer Res; 2016 Apr; 36(4):1901-7. PubMed ID: 27069178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Portal vein embolization and application of autologous stem cells in patients with primary unresectable liver tumours.
    Treska V; Koza V; Lysak D; Slauf F; Mirka H; Sutnar A; Skalicky T; Fichtl J; Ferda J
    Bratisl Lek Listy; 2013; 114(7):389-93. PubMed ID: 23822623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pros and Cons of Portal Vein Embolization With Hematopoietic Stem Cells Application in Colorectal Liver Metastases Surgery.
    Treska V; Bruha J; Liska V; Fichtl J; Prochazkova K; Petrakova T; Hosek P
    In Vivo; 2020; 34(5):2919-2925. PubMed ID: 32871833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Portal vein embolization does not affect the long-term survival and risk of cancer recurrence among colorectal liver metastases patients: A prospective cohort study.
    Collin Y; Paré A; Belblidia A; Létourneau R; Plasse M; Dagenais M; Turcotte S; Martel G; Roy A; Lapointe R; Vandenbroucke-Menu F
    Int J Surg; 2019 Jan; 61():42-47. PubMed ID: 30537548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Portal vein embolization and autologous CD133+ bone marrow stem cells for liver regeneration: initial experience.
    Fürst G; Schulte am Esch J; Poll LW; Hosch SB; Fritz LB; Klein M; Godehardt E; Krieg A; Wecker B; Stoldt V; Stockschläder M; Eisenberger CF; Mödder U; Knoefel WT
    Radiology; 2007 Apr; 243(1):171-9. PubMed ID: 17312278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Right portal vein embolization before right hepatectomy for unilobar colorectal liver metastases reduces the intrahepatic recurrence rate.
    Oussoultzoglou E; Bachellier P; Rosso E; Scurtu R; Lucescu I; Greget M; Jaeck D
    Ann Surg; 2006 Jul; 244(1):71-9. PubMed ID: 16794391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In situ split plus portal vein ligation (ISLT) - a salvage procedure following inefficient portal vein embolization to gain adequate future liver remnant volume prior to extended liver resection.
    Lehwald-Tywuschik N; Vaghiri S; Schulte Am Esch J; Alaghmand S; Klosterkemper Y; Schimmöller L; Lachenmayer A; Ashmawy H; Krieg A; Topp SA; Rehders A; Knoefel WT
    BMC Surg; 2020 Apr; 20(1):63. PubMed ID: 32252737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Preoperative Portal Vein Embolization Among Patients with Hepatocellular Carcinoma, Biliary Tract Cancer, and Colorectal Liver Metastases: A Comparative Study Based on Single-Center Experience of 319 Cases.
    Yamashita S; Sakamoto Y; Yamamoto S; Takemura N; Omichi K; Shinkawa H; Mori K; Kaneko J; Akamatsu N; Arita J; Hasegawa K; Kokudo N
    Ann Surg Oncol; 2017 Jun; 24(6):1557-1568. PubMed ID: 28188502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Stem cell-induced liver regeneration].
    Knoefel WT; Alexander A; Tustas RY; Schmelzle M; Klein HM; Krieg A; Topp SA; Eisenberger CF; Fuerst G; Schulte am Esch J
    Zentralbl Chir; 2013 Apr; 138(2):166-72. PubMed ID: 22086774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Portal vein embolization--increased chance for liver resecability for malignancies].
    Liska V; Treska V; Mírka H; Novák M; Slauf F; Skalický T; Sutnar A; Kormunda S
    Rozhl Chir; 2007 Feb; 86(2):97-101; discussion 102. PubMed ID: 17436675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor progression after preoperative portal vein embolization.
    Hoekstra LT; van Lienden KP; Doets A; Busch OR; Gouma DJ; van Gulik TM
    Ann Surg; 2012 Nov; 256(5):812-7; discussion 817-8. PubMed ID: 23095626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Future liver remnant hypertrophy rate in portal vein embolization before left trisectionectomy: a retrospective cohort study.
    Onishi Y; Isoda H; Ohno T; Shimizu H; Shimada K; Taura K; Hatano E; Nakamoto Y
    Abdom Radiol (NY); 2022 Feb; 47(2):878-884. PubMed ID: 34958405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term survival and disease recurrence following portal vein embolisation prior to major hepatectomy for colorectal metastases.
    Pamecha V; Glantzounis G; Davies N; Fusai G; Sharma D; Davidson B
    Ann Surg Oncol; 2009 May; 16(5):1202-7. PubMed ID: 19130138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of portal vein embolization on long-term survival of patients with primarily unresectable colorectal liver metastases.
    Wicherts DA; de Haas RJ; Andreani P; Sotirov D; Salloum C; Castaing D; Adam R; Azoulay D
    Br J Surg; 2010 Feb; 97(2):240-50. PubMed ID: 20087967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One or two-stage hepatectomy combined with portal vein embolization for initially nonresectable colorectal liver metastases.
    Jaeck D; Bachellier P; Nakano H; Oussoultzoglou E; Weber JC; Wolf P; Greget M
    Am J Surg; 2003 Mar; 185(3):221-9. PubMed ID: 12620560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.